Skip to main content

Table 2 Multivariable analysis for DFS in the training cohort

From: Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment

Variables HR 95% CI p value
Age 1.0431 1.006–1.082 0.024
cTNM stage    
IIIa-b vs II 1.6461 0.685–3.957 0.265
IIIc vs II 1.8162 0.622–5.302 0.275
pCR (Yes vs No) 1.229 0.4647–3.248 0.678
IMNI (Yes vs No) 0.724 0.284–1.845 0.498
HR (HR + vs HR −) 0.742 0.301–1.829 0.516
HER2 (HER2 + vs HER2 −) 0.688 0.285–1.664 0.407
Radiomics score 3.866 2.537–5.891  < 0.001
  1. HR hormonal receptor, HER2 human epidermal growth factor receptor 2, IMNI internal mammary node irradiation